These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6584388)

  • 21. Predictive testing of vulvar and cervical cancers to chemotherapy by the subrenal capsule assay.
    Mäenpää J; Kangas L; Grönroos M
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1141-6. PubMed ID: 4076281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of human adenocarcinoma to chemotherapy: as sole agents and in combination with sodium ibuprofen.
    Stratton JA; Braly PS; DiSaia PJ
    Gynecol Oncol; 1984 Jun; 18(2):145-9. PubMed ID: 6428983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High-dose chemotherapy in ovarian adenocarcinoma].
    Lotz JP; Lhommé C; Pautier P; Couteau C; Gligorov J; Alexandre J; Selle F; Izrael V; Maraninchi D; Viens P
    Bull Cancer; 2000 Jan; 87(1):63-9. PubMed ID: 10673633
    [No Abstract]   [Full Text] [Related]  

  • 24. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM
    Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphology of transplanted tumours and drug induced regression in the subrenal capsule assay (SRCA) of mice and rats.
    Stenbäck F; Wasenius VM; Kangas L
    Ann Chir Gynaecol Suppl; 1985; 199():31-7. PubMed ID: 3904585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinoma arising from a mature cystic teratoma of the ovary: a case report of successful treatment with cisplatin-based chemotherapy.
    Nasu K; Matsui N; Kawano Y; Narahara H; Hayata T; Miyakawa I
    Gynecol Obstet Invest; 1996; 41(2):143-6. PubMed ID: 8838978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of individual tumor chemosensitivity in subrenal capsule assay.
    Nishiyama M; Noso Y; Hirabayashi N; Yamaguchi M; Toge T; Niimoto M; Hattori T
    Jpn J Surg; 1986 Jul; 16(4):257-61. PubMed ID: 3095577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy responsiveness of brain tumors in subrenal capsule assay].
    Miyamachi K
    Hokkaido Igaku Zasshi; 1990 Jan; 65(1):41-9. PubMed ID: 2328945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of ATP-tumor chemosensitivity assay in primary epithelial ovarian cancer].
    Zhao D; Wu LY; Wang XB; Li XG; Li M; Li YF; Tian HM; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):368-72. PubMed ID: 20723436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer.
    Venesmaa P; Ylikorkala O
    Br J Cancer; 1991 Jan; 63(1):84-6. PubMed ID: 1899195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemosensitizing effect of an antiestrogen, toremifene, on ovarian cancer.
    Mäenpää J; Sipilä P; Kangas L; Karnani P; Grönroos M
    Gynecol Oncol; 1992 Sep; 46(3):292-7. PubMed ID: 1388131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Subrenal capsule assay--an experimental study and clinical application to chemosensitivity tests].
    Inoue K; Wang Y; Shibata H; Ueno K; Itoh Y; Tada A; Wada T; Mukaiyama T; Mitsui I; Ogawa M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1629-35. PubMed ID: 3592706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A 6-day subrenal capsule assay for predictive testing of primary esophageal cancers].
    Fukui H; Ide H; Hanyu F; Ikemoto H; Okushima N; Murata Y; Sato Y; Yamada A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1106-10. PubMed ID: 2436579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors.
    Aamdal S; Fodstad O; Kaalhus O; Pihl A
    Int J Cancer; 1986 Apr; 37(4):579-87. PubMed ID: 3957463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for ovarian adult granulosa cell tumour with synchronous endometrial adenocarcinoma.
    Ohara N; Teramoto K; Murao S
    J Obstet Gynaecol; 2002 Sep; 22(5):573-4. PubMed ID: 12521449
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor responsiveness of squamous cell carcinoma to cisplatin.
    Stiernberg CM; Valyi-Nagy K; Hale PE; Quinn FB; Bailey BJ
    Laryngoscope; 1986 Jul; 96(7):758-62. PubMed ID: 3724327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay.
    Saito T; Berens ME; Welander CE
    Cancer Chemother Pharmacol; 1987; 19(3):233-9. PubMed ID: 3107848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chemosensitivity test for bladder cancer in a nude-mice experimental system].
    Yamauchi T; Okada K; Yoshida O; Kawai T
    Hinyokika Kiyo; 1986 Dec; 32(12):1949-58. PubMed ID: 3825832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatment.
    Aamdal S; Fodstad O; Pihl A
    Ann Chir Gynaecol Suppl; 1985; 199():51-9. PubMed ID: 3864392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.